Zenflow is a San Francisco-based medical device company that develops treatments for urinary obstruction caused by benign prostatic hyperplasia (BPH). The company's flagship product is the Zenflow Spring, a small implant designed to alleviate symptoms like urinary straining and sleep disruption. It provides a minimally invasive alternative to traditional pharmaceutical and surgical options.
Zenflow was founded by the Zenflow Team. The company is a Y Combinator-backed startup headquartered in San Francisco, California, and is currently in the launched stage. They maintain a remote-friendly work environment for their full-time staff.
The Zenflow Spring is a leading medical device for treating benign prostatic hyperplasia (BPH) without the high risk of sexual side effects common in traditional surgery. It is a small implant delivered in a simple urologist's office procedure. The device is designed to provide quick and long-lasting relief for the millions of men suffering from prostate enlargement worldwide.
Urinary obstruction related to prostate enlargement (BPH) can be treated using the Zenflow Spring, an office-based implant. This procedure addresses symptoms such as frequency, urgency, and urinary straining by creating a clear flow through the prostate. It is specifically designed for patients who find drugs ineffective or wish to avoid invasive surgery.
Zenflow is located in San Francisco, California, and offers its technology through urology offices. Their website at ycombinator.com/companies/zenflow provides more information about their current stage and mission. The company's solutions are targeted at the 40 million men in the US and 500 million worldwide suffering from BPH symptoms.
The Zenflow Spring offers quick and long-lasting symptom relief for BPH through a simple procedure performed in a urologist's office. Unlike traditional surgeries, it is designed to minimize the risk of sexual side effects while maintaining effectiveness where drug treatments might fail. This makes it a significant option for improving the quality of life for men with prostate enlargement.